Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Completed · Phase 1
Conditions studied: Hodgkin Lymphoma
In brief
The purpose of this study is to establish a dosing regimen for the combination therapy of AFM13 and pembrolizumab (MK-3475) in patients with relapsed or refractory (R/R) Hodgkin Lymphoma (HL) and to assess the safety and tolerability of this combination therapy.
Key facts
- Study ID
- NCT02665650
- Run by
- Affimed GmbH
- People needed
- 30
- Starts
- 2016-05-01
- Expected to finish
- 2019-03-01
- Last updated by the study team
- 2019-05-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
- Mayo Clinic — Scottsdale, Arizona, United States
- City of Hope National Medical Center — Duarte, California, United States
- Ronald Reagan UCLA Medical Center — Los Angeles, California, United States
- Yale Cancer Center — New Haven, Connecticut, United States
- University of Miami Sylvester Comprehensive Cancer Center — Coral Gables, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University Medical Center — St Louis, Missouri, United States
- Providence Portland Medical Center, Providence Cancer Center — Portland, Oregon, United States
- University of Texas Southwestern Medical Center — Dallas, Texas, United States
- Institut Catala d'Oncologia (ICO) L'Hospitalet — L'Hospitalet de Llobregat, Barcelona, Spain
- Fundacion Privada Instituto de Investigacion Oncologica de Vall Hebron — Barcelona, Spain
- Hospital Universitario 12 de Octubre, Servicio de Hematologia — Madrid, Spain
- Salamanca University Hospital — Salamanca, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.